<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study investigated whether inhibition of <z:chebi fb="0" ids="16474">reduced nicotinamide adenine dinucleotide phosphate</z:chebi> (<z:chebi fb="1" ids="16474">NADPH</z:chebi>) oxidase attenuates <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> after transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> in rats </plain></SENT>
<SENT sid="1" pm="."><plain>Focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> (1.5 h) was produced in male Sprague-Dawley rats (250 - 280 g) by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Some rats also received treatment with 50 mg/kg <z:chebi fb="0" ids="2781">apocynin</z:chebi>, a <z:chebi fb="0" ids="50423">NADPH oxidase inhibitor</z:chebi>, by intraperitoneal injection 30 min prior to reperfusion </plain></SENT>
<SENT sid="3" pm="."><plain>Two hours after reperfusion, brains were harvested to measure <z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase activity and <z:chebi fb="1" ids="18421">superoxide</z:chebi> levels </plain></SENT>
<SENT sid="4" pm="."><plain>After 24 h, the remaining brains were harvested to investigate <z:mpath ids='MPATH_124'>infarct</z:mpath> size </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase activity and <z:chebi fb="1" ids="18421">superoxide</z:chebi> level were <z:hpo ids='HP_0000001'>all</z:hpo> augmented 2 h after reperfusion compared with controls </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="2781">Apocynin</z:chebi> treatment significantly reduced <z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase activity and <z:chebi fb="1" ids="18421">superoxide</z:chebi> levels </plain></SENT>
<SENT sid="7" pm="."><plain>Cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> size was significantly smaller in the <z:chebi fb="0" ids="2781">apocynin</z:chebi>-treated group compared with those undergoing <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e>/reperfusion alone </plain></SENT>
<SENT sid="8" pm="."><plain>These results indicate that inhibition of <z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase attenuates <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> after transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> in rats, suggesting that inhibition of <z:chebi fb="1" ids="16474">NADPH</z:chebi> oxidase may provide a therapeutic strategy for ischaemic <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>